Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IINN

Inspira Technologies Oxy... (IINN)

Inspira Technologies Oxy B H N Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IINN
DateTimeSourceHeadlineSymbolCompany
06/05/20247:30AMPR Newswire (US)Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the SectorNASDAQ:IINNInspira Technologies Oxy B H N Ltd
05/30/20247:30AMPR Newswire (US)Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant DevelopmentsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
05/28/20248:25AMPR Newswire (US)INSPIRA™ ART100 Receives FDA 510(k) ClearanceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
05/02/20248:18AMPR Newswire (US)Inspira™ Announces Start of Production of the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/25/20247:00AMPR Newswire (US)Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/16/20247:42AMPR Newswire (US)Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant ProceduresNASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/10/20247:24AMPR Newswire (US)Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream InfectionsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/03/20247:30AMPR Newswire (US)Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial WombNASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/01/20247:00AMPR Newswire (US)Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund ManagerNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/25/20248:20AMPR Newswire (US)Inspira™ Technologies Reports Full Year 2023 Financial ResultsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/18/20246:00AMPR Newswire (US)Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American MarketsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/12/20247:00AMPR Newswire (US)Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS IndicatorNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/08/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/04/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/04/20248:25AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/04/20248:20AMPR Newswire (US)Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within DaysNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/27/20246:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/27/20246:02AMPR Newswire (US)Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major MilestoneNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/27/20246:00AMPR Newswire (US)Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution AgreementsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/22/20248:18AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/22/20246:00AMPR Newswire (US)Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologiesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/14/20248:18AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/14/20246:30AMPR Newswire (US)Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/12/20243:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/12/20243:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/08/20248:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/08/20248:00AMPR Newswire (US)Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART DeviceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
01/30/20247:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
01/30/20247:30AMPR Newswire (US)Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART DevicesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
01/09/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
 Showing the most relevant articles for your search:NASDAQ:IINN